Est. 2001·3,000+ placements · six offices · four regions
BioDuro — source image

Image via Pharma Times

Partnershipcurated sourcedetected 2026-04-29 · confidence 85%

BioDuro: Partnership

BioDuro forms strategic partnership with CTI Biotechnology to create integrated platform from discovery to IND submission for preclinical drug development

Source: Pharma Times

The leadership read

Alliances like this can broaden biotech & pharma commercial leadership bench strength.

Market context: Against a Talent Market Index of 98.6 (Neutral) (down 1.4 month-on-month), Americas is at easing (-2.6pts) on signal share.

BioDuro: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 19 tracked companies; 0.1% of MitchelLake's Americas signal flow.

MitchelLake in this thematic

More signals across Biotech & Pharma

Partnership · Americas

Ratio Therapeutics

Ratio Therapeutics expanded manufacturing collaboration with PharmaLogic to add capacity and redundancy for clinical development of lead radiotherapeutic candidate BOSTON

Partnership · Americas

Bristol Myers Squibb

Bristol Myers Squibb entered into a major alliance with Chinese pharmaceutical firm Hengrui involving up to 13 drugs and valued at up to $15.2 billion. This represents significant international collaboration in drug development and commercialization.

Ma Activity · Americas

Biogen

Biogen agreed to acquire RayThera Inc., adding multiple immunology assets including a lead asset entering Phase 1 clinical development.

Product Launch · Americas

Boehringer Ingelheim

Phase 3 trial data for obesity drug survodutide shows 19% discontinuation rate due to side effects, indicating potential safety/tolerability issues that may impact market launch strategy

Product Launch · Americas

Merck & Co., Inc.

Merck presenting oncology strategy with focus on clinical progress and pipeline diversification, indicating new program developments and potential launches

Product Launch · Americas

Thermo Fisher Scientific

Thermo Fisher launched new AI-enabled Orbitrap Tribrid Apex and Orbitrap Excedion mass spectrometers at ASMS Conference, integrating with Olink proteomics and recent AI-focused software acquisitions to strengthen competitive positioning in life sciences tools.

Weekly briefing

Track companies like BioDuro — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record

Share: WhatsApp · X · Email